Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

The prognosis is usually poor in advanced hepatocellular carcinoma (HCC). Sorafenib is approved for Child-Pugh class A patients with unresectable and advanced HCC. We report here a rare case of a patient with advanced HCC with right portal vein thrombosis (PVT) who achieved a complete response after...

Descripción completa

Detalles Bibliográficos
Autores principales: Kee, Kwong-Ming, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043808/
https://www.ncbi.nlm.nih.gov/pubmed/24920924
http://dx.doi.org/10.2147/OTT.S61740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043808/
https://www.ncbi.nlm.nih.gov/pubmed/24920924
http://dx.doi.org/10.2147/OTT.S61740

Ejemplares similares